CoreAge Rx vs Corsica Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Corsica Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Corsica Health a bad call — it's best for readers who can confirm the exact formulation, total charge and applicable refund policy before purchasing a plan. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Corsica Health |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current semaglutide plan Formulation, supplied quantity and complete payment terms need confirmation; earlier $249 observation is historical. Full price detailsCurrent semaglutide formulation, plan terms and complete quote unknown; earlier listing: From $249/mo (compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $299 one-month plan advertised Injection plan; formulation needs confirmation. Three months: $747 upfront ($249/mo equivalent). Refund policies conflict. Full price detailsCurrent formulation and complete quote unknown; tirzepatide injection advertised $299 for 1 month or $747 upfront for 3 months; earlier listing: From $349/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Medication-specific state access requires confirmation; FAQ excludes sublingual semaglutide and tirzepatide in SC, AL and AR |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Corsica Health: Tirzepatide injection lists $299 for one month or $747 for three months. Formulation and refund terms need confirmation; current semaglutide product terms were unavailable.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.